Key facts
- Wittington Investments, the holding company of Canada's Weston family, has agreed to buy Boots for $8.9 billion.
- Sycamore Partners is selling the pharmacy chain.
- The deal includes Boots' UK and Ireland retail operations, Boots Opticians, No7 Beauty Company, and its Thailand and franchised businesses.
- Galen Weston, chairman of Wittington Investments, stated the firm sees an opportunity for stable long-term ownership and capital investment.
- Boots reported revenues of £7.5 billion and pre-tax profit of £337 million for the year to August 2025.
The Canadian Weston family, through its holding company Wittington Investments, has agreed to purchase the UK pharmacy and beauty retailer Boots for $8.9 billion (£6.74 billion). The deal sees Sycamore Partners exit its ownership of the Nottingham-headquartered chain.
Galen Weston, chairman of Wittington Investments, stated that Boots is "one of Britain’s most enduring businesses" and that the family sees an opportunity for "stable long-term ownership, further capital investment, and the renewed operating focus required to serve customers with excellence for generations to come."
The acquisition includes Boots' UK and Irish retail operations, its opticians chain, the No7 beauty brand, and a franchise arm in Thailand. Boots operates approximately 1,800 stores across the UK and employs 50,000 people. For the year ending August 2025, Boots reported revenues of £7.5 billion and a pre-tax profit of £337 million.
The Weston family has a history in UK retail, having previously owned the Selfridges department store chain before selling it in 2022. They also control Canadian grocery chain Loblaws and pharmacy chain Drugmart. Stefano Pessina, who has been closely associated with Boots for 20 years, will retain ownership of Boots' interests in the Farmacias Benavides pharmacy chain in Mexico and Alliance Healthcare Deutschland.